Perceived Relative Contraindications to the Administration of Influenza Vaccine during Pregnancy
| Condition | ‘Relative Contraindication’ Response | Overall | P value | |
|---|---|---|---|---|
| Family Physicians | Obstetricians | |||
| First trimester | 63.2% (36/57) | 64.7% (11/17) | 63.5% | .573 |
| Second trimester | 5.4% (3/56) | 0% (0/17) | 4.1% | .446 |
| Third trimester | 8.8% (5/57) | 0% (0/18) | 6.7% | .243 |
| Gestational diabetes | 3.6% (2/56) | 0% (0/17) | 2.7% | .586 |
| Pregnancy-induced hypertension | 11.1% (6/54) | 6.7% (1/15) | 10.1% | .523 |
| Advanced maternal age | 5.8% (3/52) | 0% (0/17) | 4.3% | .422 |
| Maternal heart disease | 1.7% (1/58) | 0% (0/19) | 1.3% | .753 |
| Maternal lung disease | 1.7% (1/58) | 0% (0/19) | 1.3% | .753 |
| History of preterm labor | 15.7% (8/51) | 5.9% (1/17) | 13.2% | .281 |
| History of intrauterine fetal demise | 14.6% (7/48) | 0% (0/15) | 11.1% | .133 |